ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Interim Money Bill Passes; NCI Can Start Awarding Grants, Contract With 1980 funds, Until Nov. 20

October 26, 1979

Study: Molecular Breast Imaging Can Be As Effective as MRI

July 27, 2012

Fibrolast Interferon Contract Signed

May 2, 1980

In Brief: Clearinghouse Charter Renewed For Two Years; Good On China, Carbone On Communciation

May 26, 1978

CMS Inserts Unprecedented Conditions Into Medicare Coverage of Lung Screening

November 14, 2014

Rhoads Suggests Plan For 200 Clinical Centers

January 28, 1977